Latest News--Shanghai Institut of Immunity and Infection, Chinese Academy of Sciences

17

2012-09

RIIP Info: The Institut Pasteur and the WHO join forces against epidemics

The Institut Pasteur and the World Health Organization (WHO) signed on September 13th in Geneva a cooperation agreement in the field of epidemic response and global health security. Their goal is to assist countries in strengthening their capacity for surveillance, detection, and response under t...

15

2012-08

A Research Breakthrough on HIV-1 Vaccine Recommended by Faculty of 1000

On Aug.13,the research paper: HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: a Desirable Vaccine Component., Journal of Virology, 2012 (DOI: 10.3410/ f. 717952409. 793457863), was recommended as being of special significance in its field by Luigi Buonaguro and Mari...

05

2012-07

Researchers Develop a Novel Strategy to Produce HIV-1 VLP as a desirable vaccine component against HIV-1

Recently，Journal of Virology online reported a seminal work on development HIV-1 virus like particles (VLP) using stably transfected Drosophila S2 cells by Professor Paul Zhou’s laboratory at the Institut Pasteur of Shanghai, Chinese Academy of Sciences.
　　Although a recent phase III studyon ...

16

2012-05

New progress on vaccine research against Highly Pathogenic Avian Influenza H5N1 Viruses

On April 10, Journal of Virology online published an article entitled “A Triclade DNA Vaccine Designed on the Basis of a Comprehensive Serologic Study Elicits Neutralizing Antibody Responses against All Clades and Subclades of Highly Pathogenic Avian Influenza H5N1 Viruses” by Professor Paul Zh...